Trial Outcomes & Findings for Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections (NCT NCT02385708)

NCT ID: NCT02385708

Last Updated: 2019-04-30

Results Overview

Number of participants who had surgical site infection development at 30 day post operative visit based on Center for Disease Control Criteria for Defining A Surgical Site Infection (SSI), 2011.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

163 participants

Primary outcome timeframe

30 days

Results posted on

2019-04-30

Participant Flow

Participant milestones

Participant milestones
Measure
Standard of Care
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Treatment Arm
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Overall Study
STARTED
81
82
Overall Study
Intervention Started
81
82
Overall Study
COMPLETED
73
67
Overall Study
NOT COMPLETED
8
15

Reasons for withdrawal

Reasons for withdrawal
Measure
Standard of Care
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Treatment Arm
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Overall Study
Withdrawal by Subject
0
2
Overall Study
Withdrawn - surgery canceled
2
5
Overall Study
Investigator decision
5
7
Overall Study
Protocol Violation
1
1

Baseline Characteristics

Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard of Care
n=73 Participants
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Treatment Arm
n=67 Participants
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Total
n=140 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
48 Participants
n=5 Participants
39 Participants
n=7 Participants
87 Participants
n=5 Participants
Age, Categorical
>=65 years
25 Participants
n=5 Participants
28 Participants
n=7 Participants
53 Participants
n=5 Participants
Sex: Female, Male
Female
26 Participants
n=5 Participants
24 Participants
n=7 Participants
50 Participants
n=5 Participants
Sex: Female, Male
Male
47 Participants
n=5 Participants
43 Participants
n=7 Participants
90 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
72 Participants
n=5 Participants
67 Participants
n=7 Participants
139 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
8 Participants
n=5 Participants
1 Participants
n=7 Participants
9 Participants
n=5 Participants
Race (NIH/OMB)
White
65 Participants
n=5 Participants
66 Participants
n=7 Participants
131 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
73 participants
n=5 Participants
67 participants
n=7 Participants
140 participants
n=5 Participants

PRIMARY outcome

Timeframe: 30 days

Number of participants who had surgical site infection development at 30 day post operative visit based on Center for Disease Control Criteria for Defining A Surgical Site Infection (SSI), 2011.

Outcome measures

Outcome measures
Measure
Standard of Care
n=73 Participants
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Treatment Arm
n=67 Participants
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Incidence of Surgical Site Infections
0 Participants
0 Participants

Adverse Events

Standard of Care

Serious events: 1 serious events
Other events: 2 other events
Deaths: 0 deaths

Treatment Arm

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Standard of Care
n=81 participants at risk
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Treatment Arm
n=82 participants at risk
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Gastrointestinal disorders
Anastomotic leak
1.2%
1/81 • Number of events 1 • From one day prior to surgery to post operative day 4
0.00%
0/82 • From one day prior to surgery to post operative day 4

Other adverse events

Other adverse events
Measure
Standard of Care
n=81 participants at risk
Patients will perform the current standard of care treatment using 2% Chlorohexidine Gluconate Cloths on the abdomen and buttocks prior to colorectal surgery night before surgery and morning of surgery 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Treatment Arm
n=82 participants at risk
Patients will receive detailed instruction for use of 2% Chlorohexidine Gluconate cloths chin to toe night before and morning of surgery then daily post operative till discharge 2% Chlorohexidine Gluconate: Use of 2% Chlorhexidine cloths chin to toes daily
Nervous system disorders
Acute altered mental status change
0.00%
0/81 • From one day prior to surgery to post operative day 4
1.2%
1/82 • Number of events 1 • From one day prior to surgery to post operative day 4
Gastrointestinal disorders
nausea/vomiting/dehydration
0.00%
0/81 • From one day prior to surgery to post operative day 4
1.2%
1/82 • Number of events 1 • From one day prior to surgery to post operative day 4
Skin and subcutaneous tissue disorders
skin rash and itching
0.00%
0/81 • From one day prior to surgery to post operative day 4
1.2%
1/82 • Number of events 1 • From one day prior to surgery to post operative day 4
Cardiac disorders
new onset atrial fibrillation with rapid ventricular response
1.2%
1/81 • Number of events 1 • From one day prior to surgery to post operative day 4
0.00%
0/82 • From one day prior to surgery to post operative day 4
Cardiac disorders
persistent tachycardia with hemodynamic instability
1.2%
1/81 • Number of events 1 • From one day prior to surgery to post operative day 4
0.00%
0/82 • From one day prior to surgery to post operative day 4

Additional Information

Steven Klintworth

Vanderbilt University Medical Center

Phone: 615-936-3298

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place